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Drosophila eye specification and development relies on a collection of transcription factors termed the retinal determination gene network
(RDGN). Two members of this network, Eyes absent (EYA) and Sine oculis (SO), form a transcriptional complex in which EYA provides the
transactivation function while SO provides the DNA binding activity. EYA also functions as a protein tyrosine phosphatase, raising the question of
whether transcriptional output is dependent or independent of phosphatase activity. To explore this, we used microarrays together with binding site
analysis, quantitative real-time PCR, chromatin immunoprecipitation, genetics and in vivo expression analysis to identify new EYA–SO targets. In
parallel, we examined the expression profiles of tissue expressing phosphatase mutant eya and found that reducing phosphatase activity did not
globally impair transcriptional output. Among the targets identified by our analysis was the cell cycle regulatory gene, string (stg), suggesting that
EYA and SO may influence cell proliferation through transcriptional regulation of stg. Future investigation into the regulation of stg and other
EYA–SO targets identified in this study will help elucidate the transcriptional circuitries whereby output from the RDGN integrates with other
signaling inputs to coordinate retinal development.
© 2007 Elsevier Inc. All rights reserved.Keywords: Eye development; Microarray; Drosophila; Cell cycleIntroduction
Regulation of gene expression is a primary means by which
signaling networks control cell fate specification. Studies of the
compound eye of Drosophila melanogaster have provided
numerous insights into how multiple signaling pathways are
integrated at the level of transcription to control proliferation
and cellular differentiation during development. The Droso-
phila eye is composed of approximately 800 units, called
ommatidia, which each contain 8 photoreceptor neurons and 12
accessory cells. The adult eye develops from a structure called
the eye imaginal disc, which consists of cells set aside in the
embryo that subsequently proliferate and differentiate during
larval and pupal development (Wolff, 1993). In the third instar
larval eye imaginal disc, a wave of differentiation, termed the
morphogenetic furrow (MF), initiates at the posterior of the disc
and moves anteriorly across the field, marking the transition⁎ Corresponding author. Fax: +1 773 702 4476.
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doi:10.1016/j.ydbio.2007.07.024from an asynchronously proliferating population of cells to G1-
arrested cells (Wolff, 1993). After specification of the initial five
photoreceptors just posterior to the MF, the remaining undiffe-
rentiated cells undergo a final mitotic division, called the second
mitotic wave, and subsequently differentiate to give rise to the
additional photoreceptors and accessory cells (reviewed by
Wolff, 1993).
Vital to the process of eye development is a network of
transcription factors, known as the retinal determination gene
network (RDGN), which are required for early eye specifica-
tion. The genes comprising the RDGN include eyeless (ey),
twin of eyeless (toy), sine oculis (so), eyes absent (eya), optix
and dachshund (dac). Loss of function of these genes results in
the complete absence of eye tissue, while overexpression in
non-retinal tissues often induces ectopic eye formation (Bonini
et al., 1993, 1997; Chen et al., 1997; Cheyette et al., 1994;
Czerny et al., 1999; Halder et al., 1995; Mardon et al., 1994;
Pignoni et al., 1997; Quiring et al., 1994; Shen and Mardon,
1997; Weasner et al., 2006). Within the RDGN, genetic epistasis
and expression analyses have positioned EYand TOYupstream
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Niimi et al., 1999; Ostrin et al., 2006; Shen and Mardon, 1997;
Zimmerman et al., 2000). Supporting the genetic data, EY has
been shown to directly regulate transcription of eya and so,
with regulation of the latter involving cooperation with TOY
(Niimi et al., 1999; Ostrin et al., 2006; Punzo et al., 2002). A
number of positive feedback loops, some of which operate at the
level of direct transcriptional control, further reinforce expres-
sion of network components to drive eye development (Bonini
et al., 1997; Bui et al., 2000b; Chen et al., 1997; Pauli et al.,
2005; Pignoni et al., 1997; Shen and Mardon, 1997).
While the regulatory relationships within the RDGN have
been worked out, much less is known about how RDGN
members modulate patterns of gene expression to yield specific
developmental outcomes. As a downstream component of the
RDGN, EYA provides a logical place to begin examining how
transcriptional output from the RDGN leads to retinal
specification. EYA family proteins are conserved from worms
to humans and are defined by a conserved C-terminal domain,
termed the EYA domain (ED). The ED is required for
interaction with SO and DAC, and also contains a phosphatase
catalytic motif (Chen et al., 1997; Li et al., 2003; Pignoni et al.,
1997; Rayapureddi et al., 2003; Tootle et al., 2003; Zimmerman
et al., 1997). EYA mediates transactivation function through its
more divergent N-terminal half, which contains a second
moderately conserved domain, the EYA domain 2 (ED2),
embedded in a proline–serine–threonine (P/S/T)-rich stretch of
amino acids (Zimmerman et al., 1997). The P/S/T-rich region is
required for transactivation, while the role of the ED2 domain
remains unclear (Silver et al., 2003; Xu et al., 1997). Given that
EYA does not have DNA binding activity, it must bind a
cofactor to be recruited to target DNA. While EYA binds both
SO and DAC through the ED (Chen et al., 1997; Pignoni et al.,
1997), only SO has been demonstrated to recruit EYA to target
DNA (Ohto et al., 1999; Silver et al., 2003). Previous studies of
EYA–SO transcriptional targets have focused on identifying SO
binding sites in target genes and showing the ability of EYA to
coregulate expression. These studies have lead to the identifica-
tion of five EYA–SO targets in Drosophila: lozenge (lz), sine
oculis (so), eyeless (ey), hedgehog (hh) and atonal (ato) (Pauli
et al., 2005; Yan et al., 2003; Zhang et al., 2006), all of which
are required for proper eye development.
As mentioned above, EYA not only functions as a
transcription factor, but also as a phosphatase. This unique
juxtaposition of functions is intriguing and begs the question of
whether phosphatase activity is required for transcriptional
regulation of EYA–SO target genes or whether the two
functions are independent. Experiments using transcriptional
reporter assays in transfected cultured cells have yielded
conflicting answers to this question (Li et al., 2003; Tootle et
al., 2003), emphasizing the necessity of additional analysis.
Although the relationship between these two EYA functions
remains to be determined, it should be emphasized that both are
required for eye development (Rayapureddi et al., 2003; Silver
et al., 2003; Tootle et al., 2003).
In order to begin exploring the relationship between EYA
phosphatase and transcription functions, we needed first toimprove our understanding of EYA's role as a transcription
factor by expanding the list of EYA transcriptional targets.
Toward this goal, we used a microarray-based approach to
identify genes whose expression was altered upon over-
expression of a wild type eya (eyaWT) transgene. In parallel,
we examined the ability of eya phosphatase mutant (eyaMUT)
transgenes to regulate these potential target genes. From our
microarray analysis, we identified 577 genes that underwent at
least a twofold change in expression upon overexpression of
wild type or phosphatase mutant eya. Comparison of the
expression profiles for tissue overexpressing wild type or
mutant eya reveals that the majority of genes have similar
expression changes across all samples. Further comparison of
the ability of EYAWT and EYAMUT to upregulate putative
targets by quantitative PCR analysis confirms that reduced
phosphatase activity may decrease EYA's transactivation
potential in some contexts, but does not eliminate its tran-
scriptional ability. Focusing on those genes that were upregu-
lated in all of our experimental samples, we asked which might
be directly regulated by EYA and SO by first identifying
potential SO binding sites in silico and then experimentally
confirming their functionality using chromatin immunopreci-
pitation (ChIP). Among the five validated targets that resulted
from this analysis, we have focused on string (stg), a Cdc25a
phosphatase that regulates the G2 to M phase transition of the
cell cycle by dephosphorylating Cdk1. Our results suggest that




Adult flies of the genotypes (1) w1118, (2) w1118; hspNeyaWT, (3) w1118;
hspNeyaD493N, and (4) w1118; hspNeyaE728Q were heat-shocked at 37 °C for 1 h,
followed by a 3-h incubation at 25 °C. Fly heads were prepared by collecting
adult males and females into microcentrifuge tubes, freezing in liquid nitrogen,
vortexing, and repeating three times. Fly headswere collected into a new tube and
50 μl of 2× reducing sample buffer (100 mM Tris–Cl (pH 6.8), 4% SDS, 20%
glycerol, 200 mMDTT) was added. Tissue was homogenized, boiled and run on
an 8% SDS–PAGE gel. Protein levels were detected with gpαEYA (1:10,000)
and mαtubulin E7 (1:5000; Developmental Studies Hybridoma Bank) using the
Li-COR imaging system and quantitated using ImageJ software (Abramoff et al.,
2004).
Microarray sample preparation and hybridization
Flies of the genotypes described above were used for microarray analysis.
Adult males and females were collected into 15-ml falcon tubes, frozen in
liquid nitrogen, and vortexed, repeating three times. Fly parts were poured onto
an RNaseZap (Ambion)-treated glass plate and 50 heads were collected into an
Eppendorf tube using a paintbrush. After homogenization in 50 μl of Trizol
reagent (Invitrogen), an additional 200 μl of Trizol was added. Four samples
were pooled for a total of 200 heads and RNAwas isolated in Trizol according
to the manufacturer's instructions and purified using the RNeasy Minikit
(Qiagen). Total RNA concentration and 260/280 ratio was determined using a
NanoDrop ND-1000 UV–Vis Spectrophotometer (NanoDrop Technologies).
cDNA synthesis was carried out according to the Expression Analysis
Technical Manual (Affymetrix, standard sample) using 2 μg of total RNA for
each sample. cRNA reactions were carried out using one cycle cDNA synthesis
according to the GeneChip Expression Analysis Technical Manual (Affyme-
trix). Ten micrograms of labeled cRNA were fragmented and hybridized to
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turer's instructions.
Microarray data analysis and binding site identification
Raw data were exported to Excel from the Affymetrix Microarray Suite,
normalized and expression ratios and t-test values calculated. For genes whose
expression was considered to be absent, the normalized filtered value was
initially set to 1, and changes in expression were confirmed by repeated analysis
in which the normalized filtered value was set to 50. Only the 577 genes which
showed a twofold change in expression levels (based on a log2 value of 1) and
had a t-test value of b0.05 in at least one of the experimental samples were used
for further analysis.
For binding site analysis, the publicly available program Genome Enhancer
(http://www.genomeenhancer.org/fly; Markstein et al., 2002) was used. Each
chromosome arm was examined individually to allow for identification of the
maximal number of clusters. Binding sites for SO targets were identified using
the following conditions: four YGATAY (Y=T/C) sites within a 50-bp window;
a single copy of the longer, more degenerate sequence described by Pauli et al.
(2005), GTAANYNGANAYS (Y=T/C, S=C/G, N=any nucleotide) in the
forward and reverse direction; one to four copies of the short sequence in
conjunction with binding sites for the transcription factors ETS (GGA(T/A)),
TCF/LEF ((T/A)(T/A)CAAAG), STAT (TTCCCGGAA), MAD (GCCGNCG),
Su(H) ((T/C)GTG(A/G)GAA) and GLI (TGGG(T/A)GGTC). See Supplemen-
tary materials and methods for further details regarding search parameters.
Conservation of binding sites was assessed using the UCSC Genome Browser
(http://www.genome.ucsc.edu/) and examining sequence alignments across
twelve Drosophila species.
Quantitative real-time RT–PCR
Adult flies of the genotypes w1118, w1118; hspNUAS eyaWT and w1118;
hspNUAS eyaE728Q were heat-shocked, 25 heads collected, and RNA isolated in
Trizol and resuspended in 16 μl nuclease-free H2O as described for microarray
sample preparation. RNA was DNase (Invitrogen)-treated for 1 h in a total
volume of 20 μl at 37 °C, followed by addition of 1 μl of 25 mM EDTA and
inactivation at 70 °C for 10 min. cDNA was generated from 1 μg of DNase-
treated total RNA using the Reverse Transcription System (Promega) according
to the manufacturer's instructions. Quantitative PCR was carried out in triplicate
on the Stratagene Mx4000 machine using 1.0 μl of the undiluted RT reaction,
0.5 μl each of 100 ng/μl sense and antisense primer, and 12.5 μl of Quantitect
SYBR Green (Qiagen) in a total volume of 25 μl. For analysis in eye–antennal
imaginal discs, 40 pairs of eye–antennal discs from third instar wandering larvae
of the genotypes GMR-Gal4 and GMR-Gal4NUAS–eya, which had been
shifted to 29 °C, 2 days after egg laying, were dissected in Schneider's S2 cell
medium and processed as described above. Quantitative real-time PCR was
carried out as described above using 0.5 μl cDNA on the ABI Prism 7700.
Relative quantification of real-time PCR product was performed using the
comparative CT method (as described in the ABI Prism 7700 Sequence
Detection System User Bulletin no. 2) and normalized by subtracting the CT
value of the control gene ribosomal protein 17 (RpS17). Primers for this analysis
are in Supplementary Table S1.
Chromatin immunoprecipitation
Eye–antennal discs were dissected from third instar larvae in Drosophila S2
media. One hundred pairs of eye–antennal discs were fixed for 15 min at room
temperature in 1 ml of S2 media with 40.5 μl of 37% formaldehyde. Glycine was
added to 125 mM and incubated for 5 minutes on ice. Discs were washed 3 times
in 1× PBS and resuspended in ChIP lysis buffer (50 mM K–HEPES pH 7.8,
140 mM NaCl, 1 mM EGTA, 1 mM EDTA, 1% Triton X-100, 0.1% Na-
deoxycholate) with protease inhibitors. Samples were kept on ice and pooled for
a total of 200 pairs of discs for each condition. Discs were homogenized with a
pestle in an Eppendorf tube 3 times and syringe passed 10 times with a 25-gauge
needle and 10 times with a 27-gauge needle, followed by incubation in lysis
buffer for 20 min at 4 °C with rocking. Discs were sonicated on ice using a
Branson digital sonifier for 15 rounds with two minutes rest in between at thefollowing settings: 15% amplitude, 15 s (.9 s ON/.1–.2 s OFF). Following
sonication, samples were spun at 13.2×103 for 10 min at 4 °C. The supernatant
from 400 total disc pairs was pooled in a new tube, and 10 μl was removed for
the input and frozen. The remainder of the supernatant was divided into equal
volumes for the control and the experimental sample (∼600 μl each). For the
control sample, pre-immune serum was added at a concentration of 1:500. For
the experimental sample, gpαSO antibody was added at a concentration of 1:500
(Mutsuddi et al., 2005). Samples were incubated overnight at 4 °C. On the
second day, Gammabind G-Protein-Coupled Sepharose beads (Amersham
Biosciences) beads were washed 2 times in 1× PBS and 20 μl of a 1:1 slurry of
the beads and lysis buffer were added to each sample and incubated for 3 h.
Samples were spun down for 2 min at 2×103 and the supernatant removed.
Beads were washed 3×5 min with ChIP lysis buffer, 1×5 min with high-salt
ChIP lysis buffer (same as above with 500 mM NaCl), 1×5 min in TE. Beads
were resuspended in 150 μl TE/SDS (10 mM Tris pH 8, 1 mm EDTA, 1% SDS)
and 140 μl TE/SDS was added to the input sample. Samples were incubated at
65 °C for 10 min, with vortexing every couple of minutes. Beads were pelleted
at 14×103 rpm for 1 min and the supernatant was removed to a fresh tube. Tubes
were sealed with parafilm and incubated at 65 °C overnight to reverse crosslinks.
Qiagen PCR purification kit was used to extract DNA. Sample was eluted in
30 μl elution buffer and PCR analysis was performed with appropriate primers
and 1–3 μl of eluted DNA. (See Supplementary Table S2 for a list of ChIP
primers.) Chromatin enrichment in the IP sample over the mock-treated sample
was determined using ImageJ (Abramoff et al., 2004).
Gel shift assays
For labeling of probes, 25 pmol of annealed oligos (see Supplementary Table
S3 for oligo sequences) were labeled with T4 polynucleotide kinase (New
England BioLabs) and 75 μCi γ-32P-dATP in a total volume of 25 μl for 30 min
at 37 °C. Kinase was inactivated by ∼20 min of incubation at 65 °C.
Recombinant GST full-length SO was purified from bacteria as previously
described (Sullivan and Ashburner, 2000). Binding reactions were carried out in
15 μl binding buffer (10 mM HEPES pH 7.9, 35 mM KCl, 10 mM NaCl, 4 mM
MgCl2, 20% glycerol, 1 mM DTT, 1 mM EDTA, 0.1% BSA), 1 μg poly dI–dC,
1 μl labeled probe, 2 μl protein and H2O in a total volume of 20 μl. Samples
were incubated for 20 min and analyzed on 6% non-denaturing polyacrylamide
gels followed by autoradioagraphy. For competition experiments, samples were
pre-incubated with 100× excess of unlabeled mutant or wild type probe for
10 min at room temperature before adding the labeled probe.
In situ hybridization
stg fragments were generated by PCR amplification from genomic DNA
using the following oligos: STG-Sense 5′-GATAATTTAGGTGACACTATA-
GAAGAGATGACGGAGAGCAACACCAACAGC-3′ and STG-Antisense 5′-
GAATTAATACGACTCACTATAGGGAGAGAAGCGGGACATTTTCGG-
TC-3′. The PCR product was gel-purified using the QIAquick Gel Extraction kit
(Qiagen) according to manufacturer's instructions. 1 μg of DNAwas used in a
total volume of 15 μl and was heated to 95 °C and cooled on ice. 2 μl of Dig
DNA labeling mix (Roche), 2 μl hexanucleotide mix (Roche) and 1 μl of
Klenow (New England BioLabs) were added and the labeling reaction was
incubated overnight at room temperature. The labeled probe was precipitated
and resuspended in 50 μl nuclease-free H2O. Eye–antennal or wing imaginal
discs were dissected from third instar larvae in Schneider's S2 cell media. Discs
were fixed in 4% paraformaldehyde for 20 min on ice, followed by incubation in
4% paraformaldehyde with 0.6% Triton X-100 for 15 min at room temperature.
Discs were washed 3×5 min in 1× PBS with 0.3% Triton and 1×5 min in PBT
(PBS+0.1% Tween-20), post-fixed in 4% paraformaldehyde for 20 min at room
temperature, washed 3×5 min in PBT, 1×5 min PBT/hybridization buffer (50%
formamide, 5× SSC, 100 μg/ml salmon sperm DNA, 100 μg/ml tRNA, 50 μg/ml
heparin, 0.1% Tween-20) and 1×5 min in hybridization buffer. Discs were pre-
hybridized in hybridization buffer for at least 1 h at 48 °C. Probe was heated to
95 °C for 3 min, cooled and added at a concentration of 1:10 for overnight
hybridization at 48 °C. Discs were washed in a PBT/hybridization buffer series,
followed by 5×20 min washes in PBT and incubation with pre-absorbed
alkaline phosphatase-conjugated anti-dioxygenin antibody (1:2000) (Roche)
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pH 9.5, 100 mM NaCl, 50 mM MgCl2, 0.1% Tween-20, 1 mM levamisol) with
3.375 μl NBT/3.5 μl BCIP (Roche).
Immunostaining
Wing imaginal discs from wandering third instar larvae were dissected in
Drosophila S2 media, fixed for 10 min in 4% paraformaldehyde with 0.1%
Triton X-100, washed 3× in PT (1× PBS, 0.1% Triton), and blocked for 30 min
in PNT (1× PBS, 0.1% Triton, 1% normal goat serum). Samples were incubated
with mouse anti-dac (1:10; Developmental Studies Hybridoma Bank) in PNT at
4 °C overnight. Samples were washed in PT, incubated with goat anti-mouse
Cy3 (1:2000; Jackson ImmunoResearch, West Grove, PA) for 2 h at room
temperature, washed in PT and mounted.
Genetics
Stocks used for microarray analysis have been previously described: HSP70-
Gal4 (Bloomington), UAS-eyaWT, UAS-eyaD493N and UAS-eyaE728Q (Tootle
et al., 2003). GMR-Gal4 (S. L. Zipursky) was used to drive eya expression in the
eye disc for qRT-PCR analysis. For genetic interactions and in vivo expression
analysis, the following stocks were used in addition to those above: DPP-Gal4
(40C6) (Staehling-Hampton et al., 1994), UAS-eyaWT/Cyo actin-GFP; stg02135/
TM3Ser actin-GFP, UAS-ey, eya2/Cyo actin-GFP; DPP-Gal4/TM6B, eya2/
Cyo actin-GFP; UAS-ey/TM6B, UAS-eyaWT, UAS-soWT/Cyo actin-GFP, and
UAS-eyaE728Q, UAS-soWT/Cyo Dfd-YFP.Fig. 1. Eya transgenes are expressed at equivalent levels. Western blot of head
lysates from flies overexpressing eyaWT, eyaD493N, and eyaE728Q.Results
Understanding the role of EYA activity in Drosophila eye
development and the extent to which EYA's phosphatase
activity influences transcriptional output requires knowledge
of its downstream transcriptional targets. At the time this project
was initiated, only a single EYA target gene, lozenge (lz), had
been identified; therefore, we used a microarray-based approach
to isolate additional genes with altered expression levels upon
eya overexpression. In parallel, we profiled tissue in which an
eya transgene mutant for phosphatase activity was over-
expressed, reasoning that if phosphatase activity is required for
transcriptional activity, then the patterns of altered gene
expression would be quite different. Despite the inherent
limitations of an overexpression-based analysis, we selected
this approach first because the eya mutant alleles predicted to
have reduced phosphatase activity behave as embryonic lethal
nulls and therefore are not suitable for array analysis in the eye
(Bui et al., 2000a;Mutsuddi et al., 2005), and second because the
requirement for EYA phosphatase activity for normal eye
development precludes us from setting up a genetic rescue
context in which eyaMUT transgenes are expressed in a
background lacking endogenous eya expression (Rayapureddi
et al., 2003; Tootle et al., 2003).
Specifically, we compared the expression profile of wild type
control tissue to that of tissue overexpressing an eyaWT transgene
or one of two eya phosphatase mutant transgenes, eyaD493N and
eyaE728Q, collectively referred to as eyaMUT (Li et al., 2003;
Rayapureddi et al., 2003; Tootle et al., 2003), under the control
of the HSP70-Gal4 driver in the adult head. Adult heads were
selected both for the ease in isolating significant quantities of
RNA, and because so, which encodes the DNA binding moiety
of the EYA–SO transcription factor, is endogenously expressed(data not shown). Eya transgenes with similar expression levels
were chosen based on quantification of protein levels onWestern
blots (Fig. 1). Tissue was harvested 3 h post-induction in order to
maximize chances that resulting changes in gene expression
would reflect direct transcriptional control, rather than down-
stream secondary effects. RNAwas extracted from adult heads in
duplicate for each genotype, processed and hybridized to Dro-
sophila Affymetrix chips (Materials and methods). Linear
regression analysis demonstrated that the replicates of each
genotype were highly similar, with control, eyaWT and eyaE728Q
samples having R2 values N0.99 and eyaD493N samples an R2
value of 0.96.
Comparison of the eyaWT, eyaD493N and eyaE728Q expression
profiles to the control sample resulted in a list of 577 genes that
demonstrated a twofold or greater change in expression with a
t-test value ofb0.05 in at least one of the experimental conditions.
In order to determine if reducing phosphatase activity altered
transactivation, we compared the expression level changes of the
577 genes in the eyaWT and eyaE728Q samples. For this com-
parative analysis, we relaxed the p value to 0.10 and the fold
change to∼1.87 in order to survey a slightly larger data set. Using
these parameters, out of the 577 genes with altered expression in
at least one of our array conditions, 452 genes had statistically
significant changes in gene expression in both the eyaWT and
eyaE728Q. Of these genes, 80% were regulated similarly between
the eyaWT and eyaE728Q samples, suggesting that reducing EYA
phosphatase activity does not globally alter transcriptional output.
These genes were also similarly regulated in eyaD493N samples,
but due to the lower correlation coefficient, often had higher p
values. Of the remaining 89 genes that were not similarly
regulated among all three array conditions, in only 9 cases were
the expression changes more similar between the two mutant
samples than between either mutant to wild type. Because this
latter pattern would be the expected signature of a gene whose
transcriptional regulation depended on EYA phosphatase activity,
our microarray-based survey suggests that loss of phosphatase
activity does not broadly alter EYA's transcriptional output.
In silico identification of SO binding sites in putative EYA
target genes
Given that EYA functions as a transcriptional activator (Ohto
et al., 1999; Silver et al., 2003), we focused our analysis of
potential targets on the 226 genes out of the initial set of 577
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samples. To identify potential direct targets of the EYA–SO
complex, two consensus sequences were used to detect the
presence of potential SO binding sites in genomic regions sur-
rounding candidate targets: a short sequence, (T/C)GATA(T/C),
identified through in vitro binding studies (Hazbun et al., 1997);
and a longer consensus sequence, GTAAN(T/C)NGANA(T/C)
(C/G) (N=any nucleotide), generated by comparison of SO
binding sites in the Drosophila transcriptional targets lz (Yan
et al., 2003) and so with sequences from targets of the mam-
malian Six family genes (Pauli et al., 2005).
Three independent computational strategies, all using the
Genome Enhancer tool (Markstein et al., 2002), were imple-
mented.We first searched for the presence of the short consensus
site (Hazbun et al., 1997) (exact search parameters described in
Materials and methods). Due to the short and somewhat
palindromic nature of this sequence, we searched for the
presence of four binding sites within a 50-bp window, but
found only two candidate targets with predicted binding sites
nearby. In a separate analysis, we searched for one copy of the
larger consensus sequence in regions proximal to genes upregu-
lated in our microarray analysis, yielding an additional nine
targets. Finally, considering the limitations of searching for such
a short binding site and the fact that the longer consensus
sequence was based only on a handful of Drosophila SO targets
and is likely to evolve further, we developed a third approach
based on the knowledge that binding sites for different tran-
scription factors often cluster in cis-regulatory elements
(Stanojevic et al., 1991). Specifically, we searched for the
short SO binding site (Hazbun et al., 1997) in combination with
identified consensus binding sites for transcription factors
downstream of canonical signaling pathways. Our search
included the binding sites for the Wingless pathway effector
TCF/LEF/PAN (van de Wetering et al., 1997), the Hedgehog
effector GLI (Kinzler and Vogelstein, 1990), the Epidermal
Growth Factor Receptor Pathway ETS family effectors (Shar-
rocks et al., 1997), the JAK/STATpathway effector STAT (Yan et
al., 1996), theNotch pathway effector Suppressor of Hairless (Su
(H)) (Rebeiz et al., 2002), and the Decapentapalegic (DPP)
pathway effector MAD (Kim et al., 1997). Searching for these
binding sites in combination with the SO binding site allowed us
to search for fewer copies of the SO binding site and to cover a
larger genomic window, thereby isolating an additional 32
potential candidate target genes. The combined results for all
three searches produced a list of 43 potential direct EYA–SO
targets that showed similar upregulation in the eyaWT and
eyaMUT array samples (Supplementary Table S4). For many of
our potential targets, more than one SO binding region was
predicted proximal to the gene of interest, suggesting the pos-
sibility of complex or tissue-specific regulation.
qRT-PCR validation of EYA targets confirms impaired
phosphatase activity has minimal impact on transcriptional
output
We next implemented a number of secondary tests to
distinguish relevant candidates from the inevitable background.First, in order to validate our microarray results independently,
we performed quantitative real-time PCR (qRT-PCR) on cDNA
derived from adult head tissue, prepared in the same manner as
that used for the microarray analysis. Genes were chosen for
analysis if they had an∼ threefold change in expression and/or a
potentially relevant molecular function. Using qRT-PCR, we
observed the upregulation of fourteen of seventeen tested target
genes upon overexpression of eyaWT (Fig. 2A and data not
shown). Although the fold changes in expression were not
identical between the microarray and qRT-PCR data, the trends
in upregulation were consistent, confirming our microarray
results.
As discussed above, our microarray data suggest that eyaMUT
transgenes retain transcriptional activity at levels similar to
eyaWT. To further validate this result, we compared the ability of
an eyaWT and an eyaMUT transgene to upregulate expression of
the genes confirmed above by quantitative real-time PCR (Fig.
2A). All ten targets tested were significantly upregulated in
response to eyaMUT, consistent with the microarray data, and six
showed statistically comparable fold activation upon expression
of either eyaWT or eyaMUT transgenes. Two, mal and CG6560,
showed a modest, less than twofold reduction in induction by
eyaMUT versus eyaWT transgenes, while stg and CG8211
exhibited a more striking ∼ threefold reduction in induction by
eyaMUT relative to eyaWT transgenes. However, even in the latter
two cases, upregulation of target gene expression by eyaMUTwas
significantly (three- to fourfold) greater than the control (Fig.
2A). These results suggest that the ability of an EYA
phosphatase mutant to activate expression of target genes is
overall quite similar to that of wild type EYA, but that there may
be some context dependency, consistent with transcription assay
data from cultured cells in which EYAMUT activated some
reporters as robustly as EYAWT, but others to a lesser degree (Li
et al., 2003; Tootle et al., 2003).
In addition, we compared the ability of eyaWT and eyaMUT
transgenes co-overexpressed with so to induce ectopic expres-
sion of dac, a gene predicted to be a direct transcriptional target
of EYA–SO, based on previous studies (Anderson et al., 2006;
Chen et al., 1997; Kenyon et al., 2005; Pignoni et al., 1997).
Both wild type EYA and the phosphatase mutant induced strong
ectopic expression of dac when overexpressed with so (Figs.
2B–D), demonstrating that EYA phosphatase activity is not
required for the expression of this downstream EYA–SO target.
Thus, loss of EYA phosphatase activity does not appear to
globally or drastically alter direct downstream transcriptional
output.
As one of the goals of this study was to identify tran-
scriptional targets of EYA relevant to eye development, we
asked if these targets could be similarly upregulated in response
to overexpressing eya in the third instar eye–antennal imaginal
disc. Using GMR-Gal4 to drive eya expression in all cells in
and behind the morphogenetic furrow, we observed upregula-
tion of twelve out of fourteen target genes by qRT-PCR (Fig.
2E, Table 1 and data not shown). These data suggest that our
adult head microarray analysis was successful in identifying
target genes that could also be regulated by EYA in the
developing eye.
Fig. 2. Overexpression of eya induces expression of putative target genes. (A) Quantitative RT–PCR analysis of target expression in adult heads overexpressing eyaWT
and eyaMUT under control of the HSP-Gal4 driver compared to adult heads of control flies. (B–D) Dac antibody staining in wing imaginal discs. (B) Wild type. (C)
DPP-Gal4 driving coexpression of eyaWT and so transgenes. (D) DPP-Gal4 driving coexpression of the phosphatase dead eyaEQ and so transgenes. (C, D) Dac
expression is induced strongly by eyaWT and eyaMUT when overexpressed with so. (E) Quantitative RT–PCR of target expression in third instar larval eye–antennal
imaginal discs overexpressing eyaWT under the control of the GMR-Gal4 driver compared to discs carrying the driver alone.
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in EYA target genes
To distinguish direct EYA transcriptional targets from genes
upregulated several steps downstream, we looked for the ability
of SO, which contributes DNA binding activity to the EYA–SO
transcription factor, to bind predicted target sequences both in
vivo and in vitro. First, we investigated whether endogenous SO
protein in the eye imaginal disc associated with chromatin
regions encompassing predicted binding sites using chromatin
immunoprecipitation (ChIP). Out of the ten candidate target
genes examined, five, plus the positive control, lz, showedenrichment of SO at one or more computationally predicted
binding sites (Fig. 3). CG8449 and CG15879 each had enrich-
ment at a single predicted binding region, stg showed enrich-
ment at each of its two predicted binding regions, whilemaroon-
like (mal) and CG12030 showed significant occupancy at each
of three predicted regulatory elements (Fig. 3). We observed SO
enrichment at binding sites predicted by all three computational
strategies described above, demonstrating the efficacy of this
approach in identifying potential targets. The association of
endogenous SO with these genomic regions during the course of
normal eye development suggests that we have identified five
new direct targets of EYA–SO transcriptional regulation, while
Fig. 3. Chromatin immunoprecipitation analysis of SO association with genomic
regions containing predicted SO binding sites. PCR-amplified product obtained
from input chromatin is in the first lane, from mock-treated sample incubated
with pre-immune serum is in the second lane, and from sample immunopre-
cipitated using the SO antibody is in the third lane. Chromatin enrichment in the
IP sample over the mock-treated sample is given below each panel.
Table 1
Predicted direct targets of EYA and SO
Gene Full name and predicted function Fold change a
WT/MUT
stg String; phosphatase 2.72/2.24
mal Maroon-like; molybdopterin sulfurase 2.83/2.63
CG12030 Galactose metabolism 5.45/6.88
CG15879 Hydrolase fold 6.11/3.12




CG6560 GTPase activity 2.95/2.73
CG15203 Novel 2.70/2.89




Eip63E Ecdysdone-inducible protein 14.83/15.19
a Fold change is indicated for eyaWT and eyaE728Q samples.
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in other developmental contexts.
Because our computational methods for identifying SO
binding sites involved searching for clustered sequence motifs,
most of the ChIP confirmed regions contained multiple
potential SO binding sequences. In order to confirm SO binding
to the predicted elements within these genomic regions and to
determine how these sequences compare with the previously
generated SO consensus binding motif, we performed electro-
phoretic mobility shift assays (EMSAs) using the two stg
genomic regions bound by SO as a test case. In these
experiments, purified recombinant full-length GST–SO fusion
protein was tested for its relative ability to bind radiolabeled
wild type oligonucleotide probes covering the predicted binding
sites versus mutant probes that no longer matched the consensus
sequence. Two predicted SO binding sites within the stg-A
region and three probes covering five potential SO binding sites
within the stg-B region were tested. While none of the mutant
probes formed a complex with SO, all wild type probes
demonstrated association with SO as evidenced by a strong
mobility shift that was competed away by excess unlabeled wild
type competitor DNA, but not by excess mutant competitor
(Fig. 4). However, SO did not bind to all probes with equal
strength. Site stg-A2 showed strongest association with SO
within the stg-A region, while stg-B3 was the most effective in
complexing with SO in the stg-B region (Fig. 4A). Assuming
comparable affinities in vivo, these data predict that stg-A2 and
stg-B3 should be the primary sites of SO recruitment to the stg
genomic locus during eye development.
To determine if the strength of SO binding could be corre-
lated with a specific sequence, we aligned the probe sequences
and looked for conserved motifs. From this analysis, only the
short SO binding site (T/C)GATA(T/C) (Hazbun et al., 1997)
emerged (Fig. 4B). Direct comparison of this sequence and
other binding sites identified in this study to the longer sequence
GTAAN(T/C)NGANA(T/C)(C/G) (N=any nucleotide) (Pauli et
al., 2005) revealed no obvious conservation of flanking se-
quences, suggesting that the core sequence requirement for
SO binding is (T/C/G)GA(A/T/G)A(T/C). Thus, how flankingsequences contribute to regulatory specificity in vivo remains an
open question.
Stg is an in vivo target of EYA–SO
In order to determine if EYA and SO regulation of stg
expression is required during development, we first tested the
ability of eya and stg to interact genetically. Specifically, we
took advantage of the fact that misexpression of EYA can induce
ectopic eye formation (Bonini et al., 1997; Pignoni et al., 1997).
In this assay, modulating the expression level of a gene predicted
to cooperate with eya in eye specification can be tested for its
ability to dominantly modify the frequency of ectopic eye
induction (Hsiao et al., 2001). Therefore, we examined the
frequency of EYA ectopic eye induction when one copy of stg
was removed. Heterozygosity for stg resulted in a 40% decrease
in the frequency of ectopic eye induction by EYA (Fig. 5),
suggesting that eya and stg function cooperatively during the
specification of eye tissue.
We next examined the ability of EYA and SO to regulate stg
expression in vivo. First, using a series of stg-lacZ enhancer trap
lines, two of which, pstgβ-E4.9 and pstgβ-E6.7, contained our
identified SO binding sites (Lehman et al., 1999), we tested the
ability of DPP-Gal4 driven EYA and SO to induce lacZ
Fig. 5. Heterozygosity for stg reduces the frequency of ectopic eye induction
upon eya misexpression under the DPP-Gal4 driver.
Fig. 4. SO binding analysis. (A) Electrophoretic mobility shift assays with
recombinant GST-full-length SO on double-stranded oligonucleotides contain-
ing predicted wild type or mutant SO binding sites. (B) Alignment of predicted
SO binding sites highlights the core consensus sequence.
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expression in the region where EYA and SO are overexpressed
was observed (data not shown). Examination of eight enhancer
trap lines spanning the 5′UTR of stg (Lehman et al., 1999) also
failed to reveal an expression pattern consistent with that of stg in
the eye imaginal disc (Alphey et al., 1992) (data not shown).
Together these results suggest that stg expression requires input
from multiple cis-regulatory regions and multiple transcription
factors. This is consistent with other studies which have shown
that stg expression is directly regulated by the epidermal growth
factor transcriptional regulators, Pointed and Tramtrack69
(Baonza et al., 2002), and directly or indirectly by Notch and
Wingless signaling (Deng et al., 2001; Johnston and Edgar, 1998).
Therefore, as an alternative to in vivo reporter analysis, we
overexpressed eya and so singly or in combination using a DPP-
Gal4 driver in third instar wing and antennal imaginal discs, both
tissues that normally lack expression of these genes, and
followed stg expression by in situ hybridization. While over-
expression of either eya or so alone did not induce stg (data not
shown), co-overexpression of both genes resulted in increased
stg along the dorsal/ventral margin of the wing and in the
ventral part of the antennal disc (Figs. 6A–D).Using the same assay, we next examined the ability of the
eyaMUT to activate stg expression when co-expressed with so.
Similar to eyaWT, eyaMUT also induced ectopic stg expression in
both the wing and antennal discs (Figs. 6E, F). The results
support our earlier microarray and qPCR data, suggesting that
reducing EYA phosphatase activity does not severely compro-
mise its transcriptional ability. However, the overproliferation
and resulting tissue distortion observed upon coexpression of so
and eyaMUT (Figs. 6C, D) was much less pronounced than that
observed with so and eyaWT (Figs. 6E, F), suggesting that
although the immediate transcriptional output might not be
significantly compromised, reduced phosphatase activity can
alter the downstream developmental program.
Although the above results are consistent with EYA and SO
directly regulating stg expression, overexpression of ey, itself a
transcriptional target of EYA–SO (Pauli et al., 2005; Pignoni et
al., 1997), has also been shown to result in upregulation of stg
(Michaut et al., 2003; Ostrin et al., 2006). Thus it was formally
possible that EYA–SO-mediated regulation of stg might occur
indirectly through EY. To rule out this possibility, we compared
the ability of EY to induce stg expression in wild type wing and
antennal imaginal discs versus discs homozygous for the eye-
specific allele eya2. This allele deletes 0.3 kb of an eye enhancer
element through which EY regulates eya expression (Zimmer-
man et al., 2000). As expected based on the results of Michaut et
al. (2003), overexpression of ey using a DPP-Gal4 driver
resulted in increased stg expression in wing and antennal discs
(Figs. 6G, H). Antibody staining revealed induction of eya and
so expression in these tissues (data not shown), suggesting that
stg upregulation could be directed by EYA and SO. In contrast,
in discs overexpressing ey, but lacking eya, we no longer
observed stg induction in wing or antennal discs, indicating that
EYA and SO function downstream of EY to directly regulate stg
transcription (Figs. 6G–J).
The ability of EYA and SO to induce ectopic stg expression
demonstrates that EYA and SO are sufficient for stg expression,
and the fact that EY cannot induce stg in the absence of eya
suggests that eya is also necessary. Further supporting the
Fig. 6. EYA and SO regulation of stg expression. (A–J) In situ hybridization for stg. Wild type eye–antennal (A) or wing imaginal disc (B) show strong stg
expression. Eye–antennal (C) or wing (D) imaginal discs overexpressing eyaWT and so under the control of the DPP-Gal4 driver. In both tissues, stg expression
is induced in the region where eya and so are being overexpressed. Eye–antennal (E) and wing (F) imaginal discs in which eyaMUT and so are overexpressed
under the control of the DPP-Gal4 driver demonstrate ectopic stg expression. Arrows in panels C–F indicate regions of increased stg expression. Overexpression
of ey using a DPP-Gal4 driver induces stg expression in eye–antennal (G) and wing imaginal discs (H). Discs overexpressing ey, but homozygous for the eya2
allele no longer exhibit induction of stg expression (I, J). In eya2/eya2; DPP-Gal4/UAS-ey wing discs significant folding is observed, which results in the darker
stg staining in the region of ey overexpression but does not reflect an overall increase in stg expression.
424 J. Jemc, I. Rebay / Developmental Biology 310 (2007) 416–429argument that eya is necessary for stg expression, loss of eya
also compromises the normal pattern of stg expression at the
morphogenetic furrow (Figs. 6A, I), demonstrating that eya is
required for stg expression during eye development. However,
we still observe tissue overgrowth in wing discs overexpressing
ey and mutant for eya (Figs. 6I, J), indicating that EY may act
through additional parallel pathways to influence cell prolifera-
tion and organ size. This may also be the case for EYA and SO,as heterozygosity for stg was unable to rescue tissue overgrowth
in wing discs overexpressing eya and so (data not shown). These
observations are consistent with previous data demonstrating
that overexpression of stg alone does not increase cell
proliferation (Neufeld et al., 1998). Thus, the ability of EYA
and SO to induce stg outside of its normal expression region,
coupled with our demonstration that eya is necessary for stg
expression in the eye imaginal disc, suggest that a direct
425J. Jemc, I. Rebay / Developmental Biology 310 (2007) 416–429mechanism through which EYA and SO might regulate cell
cycle progression during eye development.
Discussion
We have used microarray analysis combined with computa-
tional and experimental validation to identify potential EYA–
SO transcriptional targets. Two general conclusions have re-
sulted from this work: first, the similarity in expression profiles
between tissue overexpressing wild type and phosphatase-dead
eya transgenes and analysis of gene expression by quantitative
PCR suggest that EYA's phosphatase activity is not generally
required for EYA transcriptional activity, although it may be
required for maximal transactivation of some target genes; and
second, the short sequence (T/C/G)GA(A/T/G)A(T/C) appears
to be the only recognizable motif shared among all SO binding
sites. As exemplified by our in vivo validation of EYA–SO-
mediated regulation of the cell cycle regulator stg, further
analysis of the target genes identified in this study will likely
shed new light into the mechanisms underlying EYA–SO
function during development.
Identification of new EYA–SO targets
The main goal of this study was to identify new targets of
EYA transcriptional activity. Although we used adult head
tissue for our overexpression experiments, our 86% success rate
in confirming changes in expression of our potential targets in
developing Drosophila eye–antennal imaginal discs overex-
pressing eya supports the ability of this system to identify
similar data sets in different developmental stages. Out of the
ten genes upregulated by eya overexpression in both adult head
tissue and eye–antennal imaginal discs, five demonstrated
enrichment of endogenous SO at one or more predicted binding
sites. These predicted binding regions were conserved across a
minimum of two and up to nine Drosophila species, emphasiz-
ing their likely biological relevance (data not shown; see
methods for details). Two binding sites that did not demonstrate
SO enrichment were not conserved across other Drosophila
species, while binding sites in the remaining three genes were
conserved across multiple species and could be EYA–SO
targets in other tissues.
The core sequence shared by all of these targets is (T/C/G)GA
(A/T/G)A(T/C), a pared down version of the previously pro-
posed GTAAN(T/C)NGANA(T/C)(C/G) SO binding sequence
(Pauli et al., 2005). In Drosophila EYA–SO targets, the se-
quence flanking the core (T/C/G)GA(A/T/G)A(T/C) has only
been shown to be important in the case of the target so (Pauli
et al., 2005), and is absent in one of the two SO binding sites
identified in the lz locus (Yan et al., 2003) and in the binding
sites in stg we confirmed by gel shifts. While specific flanking
sequences may further stabilize SO–DNA interactions, char-
acterization of such a flanking sequence consensus awaits
further analysis. Confirmation of additional targets predicted by
our microarray and binding site analysis should provide for
further characterization of the SO binding sequence. Out of the
remaining 31 potential targets, all except one have binding sitesconserved across multiple Drosophila species, suggesting that
additional EYA–SO targets will be confirmed within this data
set.
While none of the previously identified EYA–SO targets
were included in our final list, two targets, so and lz were
upregulated upon eya overexpression, although less than our
twofold cutoff. The expression of the previously identified
targets hh, ato and ey was either absent or changes were not
statistically significant. One explanation for this observation is
that other signaling pathways required for the expression of
these genes may not be activated, or, conversely, inhibitory
signaling pathways could be activated in adult head tissue.
In addition to examining expression levels of previously
identified EYA–SO targets, we also compared our list of
upregulated EYA–SO target candidates to genes that were
upregulated by ey overexpression in microarray analyses
(Halder et al., 1998; Niimi et al., 1999; Ostrin et al., 2006;
Pauli et al., 2005; Punzo et al., 2002). Because ey both induces
eya and so expression and is itself transcriptionally regulated by
EYA–SO, one would expect to see a number of genes similarly
regulated by overexpression of either ey or eya; however, as
detailed below, pairwise comparisons between our data set to
lists of candidate ey targets derived from two independent array
studies (Michaut et al., 2003; Ostrin et al., 2006), reveals a
surprisingly limited overlap. Michaut et al. identified 371 genes
with at least 1.5-fold upregulation across two array experiments,
only 55 of which were similarly upregulated in both arrays
(Michaut et al., 2003). Comparison of this data set to a more
recent report by Ostrin et al. of 300 candidate genes upregulated
in response to ey overexpression revealed only 24 common
targets. Comparison to our list of potential eya–so targets
yielded 10 shared with the Michaut et al. data set and 3 common
to the Ostrin et al. results. Encouragingly, despite this limited
overlap, stg, a gene we have shown here to be transcriptionally
regulated by eya and so, was one of the two targets consistently
upregulated in all three studies (Michaut et al., 2003; Ostrin et
al., 2006).
As we continue to confirm additional targets, it is important
to note that EYA may also associate with transcription cofactors
other than SO to regulate gene expression. Although EYA can
associate with DAC (Chen et al., 1997), and X-ray crystal-
lographic analysis suggests that DAC can bind DNA (Kim et
al., 2002), targets of an EYA–DAC complex or a consensus
DAC binding site have not been identified. In addition, EYA
also contains an engrailed homology 1 (eh1) domain (Goldstein
et al., 2005), suggesting that it may be able to bind to the
transcriptional repressor Groucho (GRO). However, as current
in vivo data only supports a role for EYA as a transactivator
complexed to SO, identification of additional EYA cofactors in
vivo will be necessary to explore the potential of SO-
independent EYA transcriptional functions further.
Interplay between EYA transcription and phosphatase
activities
Previous studies using transcriptional reporter assays in
transfected cultured cells have yielded conflicting results as to
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tional output from EYA–SO (Li et al., 2003; Tootle et al., 2003).
However, the emerging consensus from these experiments is
that missense mutations in the ED that reduce phosphatase
activity also compromise the ability of EYA to transactivate
targets (Li et al., 2003; Mutsuddi et al., 2005). Importantly,
these mutations do not affect SO binding (Mutsuddi et al., 2005;
Tootle et al., 2003), suggesting that it is actually loss of EYA
phosphatase activity that alters transcriptional output, presum-
ably as a consequence of improper phosphoregulation of critical
substrates, although altered protein–protein interactions cannot
be ruled out. How faithfully these cultured cell-based reporter
assays mirror in vivo regulation remains an open question.
In order to examine further the relationship between EYA's
dual functions as transcriptional coactivator and protein tyro-
sine phosphatase in vivo, we compared the expression profiles
of tissue overexpressing wild type versus phosphatase mutant
eya transgenes. We expected that if phosphatase activity is
required for transactivation, then direct transcriptional targets
showing altered expression in eyaWT samples would exhibit
reduced changes in eyaMUT samples. Our microarray results
demonstrated that ∼80% of a set of 452 candidate targets were
similarly regulated among eyaWT and eyaMUT samples, sup-
porting the alternate hypothesis that phosphatase activity is not
broadly required for EYA's transcriptional activity. Only 2%,
or 9 genes, exhibited a consistent change in expression in
response to the two eyaMUT transgenes that differed from the
response to eyaWT. Our follow-up analysis of a subset of these
genes by quantitative PCR confirmed that an EYA phosphatase
mutant has transcriptional activity quite similar to wild type
EYA. In the cases in which phosphatase mutant EYA induced
expression at a significantly lower level that wild type EYA,
one hypothesis would be that those genes might represent
indirect targets; arguing against this, stg, one of two genes
whose pattern of induction fell into this category, was con-
firmed as a direct EYA–SO target. In addition, ectopic expres-
sion of dac, a likely direct downstream EYA–SO target, was
induced by the eyaMUT as efficiently as eyaWT. In conclusion,
while mutating EYA phosphatase activity has a minimal impact
on the direct downstream transcriptional profile overall, at
certain target genes it may reduce, but not eliminate trans-
criptional output. Given these results, future exploration of in
vivo roles for EYA phosphatase activity independent of its
transcriptional functions may be warranted.
Disease and developmental implications of EYA–SO targets
Many of the genes identified as direct EYA–SO transcrip-
tional targets are largely uncharacterized “CGs” whose expres-
sion patterns in the eye will have to be studied in detail to gain
further insight to EYA–SO-mediated regulation, but a few have
predicted or well-studied functions that may provide insight into
how EYA–SO functions during normal development and how
misregulation can result in disease. Most notable on this list is
stg. Given that overexpression of eya and so results in over-
proliferation, while their loss leads to tissue reduction (Bonini
et al., 1997; Pignoni et al., 1997), EYA–SO control of stgexpression provides a mechanism for how EYA–SO regula-
tion of the cell cycle may in turn affect cell proliferation. An
interesting question for future investigation is how the
relatively broad expression of EYA and SO throughout the
developing retina activates stg expression only in a relatively
narrow stripe of cells just anterior to the morphogenetic
furrow. Given the apparent complexity of stg cis-regulatory
elements revealed by our and previous studies (Baonza et al.,
2002; Deng et al., 2001; Johnston and Edgar, 1998), a likely
explanation is that EYA–SO act combinatorially with
transcriptional effectors of other signaling pathways to effect
this developmental precision.
Consistent with eya and so overexpression leading to
increased tissue overgrowth in Drosophila (Bonini et al.,
1997; Pignoni et al., 1997), elevated levels of Eya and Six
family members have been observed in a variety of cancers
(Coletta et al., 2004; Ford et al., 1998; Yu et al., 2006; Zhang et
al., 2005). Studies of the transcriptional targets of mammalian
Eya and SO/Six proteins have identified the cell cycle regulatory
genes, cyclin D1 and cyclin A1 (Coletta et al., 2004; Yu et al.,
2006), the proto-oncogene c-Myc (Li et al., 2003) and ezrin (Yu
et al., 2004), a regulator of the cytoskeleton and contributor to
metastasis, suggesting intermediates through which Eya and Six
family genes regulate proliferation and contribute to cancer.
Identification of stg as a transcriptional target of EYA and SO in
Drosophila provides not only the first direct cell cycle target in
Drosophila, but also suggests another target through which EYA
and SO might regulate proliferation in other organisms.
Before we can draw parallels to how EYA–SO targets
important for Drosophila retinal development might be relevant
to development and disease in other organisms, it will be
necessary to examine the conservation of the transcriptional
regulatory circuits. However, given the predicted functions of
the gene products encoded by our candidate EYA–SO targets,
together with knowledge of Eya–Six function in mammalian
systems, it is tempting to speculate. For example, CG12030, the
Drosophila homolog of the human Gale, encodes a sugar
epimerase required for galactose metabolism (predicted by
Interpro (Apweiler et al., 2000)). As metabolic abnormalities
have been demonstrated to play a part in cataract formation, and
mutations in eya have been observed in patients with congenital
cataracts (Azuma et al., 2000), the identification of CG12030 as
an EYA–SO target suggests that intermediates through with eya
might function to maintain homeostasis in the eye. Mal, which
encodes a molybdenum cofactor sulfurase important for
ommochrome biosynthesis, is expressed in Drosophila pigment
cells in the eye (Amrani et al., 2000) and would seem a logical
target of the RDGN. Mutations of the human homolog of mal,
HMCS, can result in renal failure and myositis (Ichida et al.,
2001), both intriguing phenotypes given the importance of
Eya–Six in vertebrate kidney and muscle development
(Abdelhak et al., 1997; Grifone et al., 2005; Heanue et al.,
1999; Laclef et al., 2003; Li et al., 2003; Ozaki et al., 2001; Xu
et al., 1999, 2003). CG15879 encodes the Drosophila homolog
of human SERHL2, a member of a serine hydrolase-like family
predicted to regulate muscle growth, a developmental context in
which Eya and Six family genes function in Drosophila and
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al., 1999; Laclef et al., 2003; Li et al., 2003). Lastly, CG8449
has a predicted RabGAP/TBC domain. While RabGAPs
function in a variety of developmental contexts, RabGAP-like
proteins have been predicted to function in phototransduction
and synaptic transmission in Drosophila (Xu et al., 1998) and
mutations in RabGAP genes have been isolated in cases of
Warburg Micro syndrome (Aligianis et al., 2005), a severe
autosomal recessive disorder characterized by abnormalities in
the eye, as well as the central nervous system and genitals, all
contexts in which Drosophila eya and so are expressed (Bonini
et al., 1998; Boyle et al., 1997; Cheyette et al., 1994; Fabrizio et
al., 2003). Identification of additional EYA–SO targets and the
examination of the conservation of EYA–SO transcriptional
regulation across homologous genes in different species will be
necessary to determine how EYA and contribute to develop-
ment and disease.
Given the importance of achieving appropriate levels of gene
expression during the course of development, it is not surprising
that multiple signaling pathways converge to regulate common
target genes at the level of transcription. For example, hh and lz
are coordinately regulated by receptor tyrosine kinase (RTK)
downstream effectors of the ETS family (Behan et al., 2002;
Rogers et al., 2005) in conjunction with EYA and SO. Here, we
have identified stg as an EYA–SO target, and work by us and
others suggests that stg transcription is also regulated by Notch
and Wingless (Wg) signaling (Deng et al., 2001; Johnston and
Edgar, 1998) and by RTK signaling (Baonza et al., 2002). Thus,
our results suggest a mechanism by which members of the
RDGN are integrated with Notch and Wg signaling to
coordinate cell proliferation. Identification of additional
EYA–SO targets is likely to reveal new nodes for integration
of the RDGN with other signaling pathways, explaining how
signaling pathways cooperate to yield specific developmental
outcomes.
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